Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Vries

Showing results (161-170 of 273) with videos related to

Pageof 28
Sort By:
Journal of Virology|February 14, 2018
<i>In Vitro</i> Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B CellsBrigitta M Laksono, Christina Grosserichter-Wagener, Rory D de Vries, et al.
Biomedicines|September 28, 2023
Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in <i>Cyp2c70</i><sup>-/-</sup> Mice with a Human-like Bile Acid CompositionAnna Palmiotti, Hilde D de Vries, Milaine V Hovingh, et al.
Msphere|June 28, 2023
Infection of ferrets with wild type-based recombinant canine distemper virus overwhelms the immune system and causes fatal systemic diseaseBrigitta M Laksono, Dagmar Roelofs, Anouskha D Comvalius, et al.
Science Immunology|November 2, 2019
Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measlesVelislava N Petrova, Bevan Sawatsky, Alvin X Han, et al.
NPJ Vaccines|December 22, 2017
Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protectionRik L de Swart, Rory D de Vries, Linda J Rennick, et al.
Scientific Reports|April 26, 2018
Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccinesArwen F Altenburg, Stella E van Trierum, Erwin de Bruin, et al.
Frontiers in Immunology|May 3, 2024
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination programLeanne P M van Leeuwen, Marloes Grobben, Corine H GeurtsvanKessel, et al.
JMIR Public Health and Surveillance|February 12, 2025
A Call for Action: Lessons Learned From a Pilot to Share a Complex, Linked COVID-19 Cohort Dataset for Open ScienceClara Amid, Martine Y van Roode, Gabriele Rinck, et al.
Science (New York, N.Y.)|November 2, 2019
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogensMichael J Mina, Tomasz Kula, Yumei Leng, et al.
Scientific Reports|August 19, 2017
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In VivoArwen F Altenburg, Carolien E van de Sandt, Bobby W S Li, et al.
Pageof 28

Showing results (161-170 of 273) with videos related to

Sort By:
Pageof 28
Journal of Virology|February 14, 2018
<i>In Vitro</i> Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B CellsBrigitta M Laksono, Christina Grosserichter-Wagener, Rory D de Vries, et al.
Biomedicines|September 28, 2023
Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in <i>Cyp2c70</i><sup>-/-</sup> Mice with a Human-like Bile Acid CompositionAnna Palmiotti, Hilde D de Vries, Milaine V Hovingh, et al.
Msphere|June 28, 2023
Infection of ferrets with wild type-based recombinant canine distemper virus overwhelms the immune system and causes fatal systemic diseaseBrigitta M Laksono, Dagmar Roelofs, Anouskha D Comvalius, et al.
Science Immunology|November 2, 2019
Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measlesVelislava N Petrova, Bevan Sawatsky, Alvin X Han, et al.
NPJ Vaccines|December 22, 2017
Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protectionRik L de Swart, Rory D de Vries, Linda J Rennick, et al.
Scientific Reports|April 26, 2018
Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccinesArwen F Altenburg, Stella E van Trierum, Erwin de Bruin, et al.
Frontiers in Immunology|May 3, 2024
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination programLeanne P M van Leeuwen, Marloes Grobben, Corine H GeurtsvanKessel, et al.
JMIR Public Health and Surveillance|February 12, 2025
A Call for Action: Lessons Learned From a Pilot to Share a Complex, Linked COVID-19 Cohort Dataset for Open ScienceClara Amid, Martine Y van Roode, Gabriele Rinck, et al.
Science (New York, N.Y.)|November 2, 2019
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogensMichael J Mina, Tomasz Kula, Yumei Leng, et al.
Scientific Reports|August 19, 2017
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In VivoArwen F Altenburg, Carolien E van de Sandt, Bobby W S Li, et al.
Pageof 28